
AbbVie announced a quarterly cash dividend of $1.73 per share, payable on August 14, 2026, to shareholders of record as of July 15, 2026. Since its founding in 2013, AbbVie has increased its dividend by over 330%, reflecting its strong commitment to returning value to shareholders. The company is recognized as a member of the S&P Dividend Aristocrats Index, highlighting its consistent dividend growth for at least 25 years. This dividend declaration underscores AbbVie's financial stability and ongoing focus on rewarding investors.